In vivo administration of NKT cell ligand, α-galactosylceramide (α-GalCer), caused the activation of NKT cells to induce a strong NK activity and cytokine production by CD1d-restricted mechanisms. Surprisingly, we also found that α-GalCer induced the activation of immunoregulatory cells involved in acquired immunity. Specifically, in vivo administration of α-GalCer resulted in the induction of the early activation marker CD69 on CD4 ⍣ T cells, CD8 ⍣ T cells and B cells in addition to macrophages and NKT cells. However, no significant induction of CD69 was observed on cells from CD1d-or V α 14 NKT-deficient mice, indicating an essential role for the interaction between NKT cells and CD1d-expressing dendritic cells (DC) in the activation of acquired immunity in response to α-GalCer. Indeed, in vivo injection of α-GalCer resulted not only in the activation of NKT cells but also in the generation of CD69 ⍣ CD8 ⍣ T cells possessing both cytotoxic T lymphocyte (CTL) activity and IFN-γ-producing ability. Tumor-specific CTL generation was also accelerated by α-GalCer. The critical role of CD40-CD40 ligand (CD40L)-mediated NKT-DC interaction during the development of CD69 ⍣ CD8 ⍣ CTL by α-GalCer was demonstrated by blocking experiments using anti-CD40L mAb. These findings provide direct evidence for a critical role of CD1d-restricted NKT cells and DC in bridging innate and acquired immunity.
Introduction
Immune systems are classified into two general systems, the infectious agents during evolution (1). It is thought that the innate immune system initially keeps the infection under innate or natural immune system and the acquired or adaptive immune system. These systems may have been selected by control, saving time for the adaptive immune system to develop an appropriate response. However, recent studies Methods have suggested that the various components of the innate Mice immune system trigger and augment the components of the C57BL/6 mice were purchased from Charles River Japan adaptive immune system, including antigen-specific B and T (Yokohama, Japan). V α 14 NKT cell-deficient (J α 281 -/-) and lymphocytes (1-3). It is now clear that the innate and adaptive CD1d -/-mice were established by specific deletion of the immune systems intimately interact with one another, and that J α 281 and CD1d gene segment respectively (17, 20) . All mice adaptive immunity is controlled by the components of innate used in this study were 5-8 weeks old and were maintained immunity (2,4).
in specific pathogen-free conditions. Cells of the innate immune system, including macrophages and dendritic cells (DC), take up foreign antigens through α-GalCer pattern recognition receptors, combine peptide fragments of α-GalCer, [(2S,3S,4R)-1-O-(α-D-galactopyranosyl)-2-(N-hexathese antigens with MHC class I and class II molecules, cosanoylamino)-1,3,4-octadecanetriol], used for this study and stimulate naive CD8 ϩ and CD4 ϩ T cells respectively was provided by Dr Y. Koezuka (Kirin Brewery, Gunma, Japan) (4-6). In addition, professional antigen-presenting cells (APC) (18) . The stock solution of α-GalCer (220 µg/ml) was diluted communicate with T cells using positive and negative feedin 0.5% polysorbate 20 (Nikko Chemical, Tokyo, Japan) in back systems, by producing cytokines such as IL-12, IL-18 0.9% NaCl solution. This stock solution was further diluted and IL-10 (7-9). These interactions will influence the differentiinto an appropriate concentration with saline and used for ation of naive CD4 ϩ T cells into T h 1 or T h 2 lymphocytes the experiments. A vehicle control solution was prepared from that mediate cellular and humoral immunity respectively a solution of 0.5% polysorbate 20 in 0.9% NaCl solution. The (10-12). In order to understand host immune defenses against vehicle control was used in all experiments. pathogenic microorganisms it is therefore important to study the molecular and cellular mechanisms that bridge innate
Isolation of lymphoid cell subsets by FACS and acquired immunity.
Spleen cells were incubated on nylon-wool columns for 45 Recently, a novel lymphoid lineage, V α 14 NKT cells, distinct min and the non-adherent cells were used for the isolation of from mainstream T cells, B cells and NK cells, has been CD4 ϩ T cells and CD8 ϩ T cells by cell sorting using a FACS identified (13,14). These cells are characterized by co-expresVantage instrument (Becton Dickinson, Mountain View, CA). sion of NK cell receptors and semi-invariant TCR encoded All mAb used in these experiments [mAb against NK1.1 by V α 14 and J α 281 gene segments. Upon activation, NKT cells (PK136), CD3 (145-2C11), CD4 (GK1.5), CD8a (53-6.7), produce high levels of IFN-γ and IL-4, and can influence CD11b/Mac-1 (M1/70), CD11c (HL3), CD45/B220 (RA3-6B2) immune responses against autoantigens and tumors (15,16).
and CD69 (H1.2F3)] were purchased from PharMingen (San These cells were therefore implicated as key effector cells in Diego, CA). The stained cells were isolated using FACS innate immune responses. However, the potential role of vantage. The purity of the sorted cells was Ͼ98%. The details NKT cells in the development of adaptive immune responses of the staining and sorting have been described earlier (21) . remains unclear. Recently, it was demonstrated that NKT cells can be activated by the glycolipid α-galactosylceramide Detection of cytokine activity (α-GalCer) bound with the MHC class I-like molecule CD1d IL-4 or IFN-γ activity in serum samples or culture supernatants (17,18). In vivo administration of α-GalCer induced strong was determined using the Biotrac mouse IL-4 or Biotrac cytolytic activity and cytokine production in wild-type mice, mouse IFN-γ ELISA system (Amersham, Little Chalfont, UK). but not CD1d-or NKT-deficient mice. Furthermore, using Serum samples were obtained from C57BL/6 mice 24 h after highly purified cell populations, we demonstrated that injection of α-GalCer (2 µg/mouse) and cytokine levels were α-GalCer selectively activates NKT cells, and that this measured using ELISA kits (Amersham). responses required CD11c ϩ DC and CD40-CD40 ligand (CD40L) interactions (19). This chemical therefore allowed us Cytotoxicity assay to directly test whether the interaction between NKT cells and The NK activity of spleen cells was determined by 4 h DC early in an immune response affects the subsequent 51 Cr-release assays using YAC-1 cells as target. Reverse development of an adaptive immune response.
antibody-dependent cellular cytotoxicity (R-ADCC) CTL In the present paper we demonstrate that in vivo administraactivity was measured using Fc receptor-positive P815 mastotion of the NKT cell ligand α-GalCer induces the expression cytoma cells in the presence of anti-CD3 mAb. Tumor antigenfor the early activation marker CD69 on conventional CD4 ϩ specific CTL activity was detected using MBL-2 T lymphoma and CD8 ϩ T cells, B cells, macrophages and NKT cells. cells. One lytic unit was defined as the number of effector These effects of α-GalCer were absent in CD1d-and NKT cellcells required to cause 25% lysis of 2500 target cells. The deficient mice. We further showed that activation of CD69 on cytotoxicity (%) was calculated as described previously CD8 ϩ T cells resulted in the acquisition of a cytolytic pheno-(13,22). type and IFN-γ production. Administration of anti-CD40L antiQuantitative RT-PCR assay for IL-12 receptor (IL-12R) mRNA bodies prior to treatment with α-GalCer blocked the activation measurement of CD8 ϩ T cells. These findings provide direct evidence that antigen presentation by CD1-and CD40-expressing DC to C57BL/6, CD1d -/-and V α 14 NKT cell-deficient mice were NKT cells is critically important for bridging innate and adaptinjected i.v. with α-GalCer (2 µg/mouse) or vehicle. At 4 h after treatment, mice were sacrificed and spleen cells were ive immunity. 
isolated. TaqMan real-time quantitative RT-PCR assay was
The generation of tumor antigen-specific CTL by α-GalCer administration in vivo carried out for the detection of IL-12R mRNA expression by these cells according to the method previously described C57BL/6 mice were hyperimmunized with mitomycin C-treated (19). IL-12Rβ1 and IL-12Rβ2 mRNA expression was estimated syngeneic MBL-2 T lymphoma cells twice with a 2 week from the ratio of fluorescence intensity as compared with interval. This protocol is sufficient to induce antitumor memory GAPDH. IL-12R expression induced by α-GalCer was indi-T cells, as described previously (23). Then, the immunized cated in Table 1 as an induction index, which was calculated mice were i.v. injected with 2 µg/mouse of α-GalCer twice in by the following formula: induction index ϭ (IL-12R expression 2 day intervals. Six hours after the final boosting with α-GalCer, of α-GalCer-stimulated sample/IL-12R expression of unstimu-CD8 ϩ T cells, CD8 ϩ CD69 -T cells and CD8 ϩ CD69 ϩ T cells lated sample) ϫ100.
were isolated from the spleen by flow cytometry, and their TaqMan probes used for these analyses are as follows:
ability to differentiate into tumor antigen-specific CTL was IL-12Rβ1 mRNA-605T: 5Ј-CGGATGCCCACAACGAATTGGAassessed after culture with IL-2 plus IL-12 for 2 days. The 3Ј; IL-12Rβ2 mRNA-551T: 5Ј-AGCCACCTCAAAACATATCATgeneration of tumor-antigen-specific CTL was determined by GTGTCCAGG-3Ј; GAPDH-542T: 5Ј-CCTGGCCAAGGTCATCmeasuring their cytotoxicity against MBL-2 T lymphoma cells. CATGACAACTTT-3Ј.
As control target cells, syngeneic B16 melanoma cells were PCR primers used for these analyses are as follows: IL-12β1 used. mRNA: forward primer (-563F) 5Ј-AATGTGTCTGAAGAGGC-CGGT-3Ј and reverse primer (-657R) 5Ј-GAGTTAACCTGAGBlocking of IL-12R induction by anti-CD40L mAb GTCCGCAGT-3Ј; IL-12Rβ2 mRNA: forward primer (-529F) 5Ј-Wild-type C57BL/6 mice were injected i.p. with 100 µg anti-ATCTCAGTTGGTGTTGCTCCA-3Ј and reverse primer (-602R) CD154 (CD40L) mAb (MR1; PharMingen) at 0 and 1 days 5Ј-GCCACAGTTCCATTTTCTCCT-3Ј; GAPDH: forward primer before priming with α-GalCer. As a control, the same amount (-368F) 5Ј-CTTCACCACCATGGAGAAGGC-3Ј and reverse of hamster IgG (PharMingen) was injected i.p. into control primer (-605R) 5Ј-GGCATGGACTGTGGTCATGAG-3Ј. mice prior to injection of α-GalCer.
Immunopotentiating effect of α-GalCer in vivo Results C57BL/6 mice were i.v. injected with α-GalCer (2 µg/mouse) and the mice were sacrificed 4-6 h after the treatment to
Immunopotentiating effect of α-GalCer in vivo examine serum cytokine levels, NK activity, IL-12R induction and acquisition of the early activation marker CD69 in spleen Consistent with previous findings (17-19), in vivo administration of α-GalCer caused the elevation of both IL-4 and IFN-γ cell subpopulations. The generation of CD8 ϩ CTL was investigated using the purified CD8 ϩ CD69 ϩ T cells or CD8 ϩ CD69 -levels. α-GalCer administration also resulted in the activation of NK activity mediated by NKT cells. Moreover, α-GalCer T cells from the spleen of α-GalCer-injected mice. The acquisition of non-specific CTL activity was determined by measuring administration caused the induction of IL-12R β1 and β2 mRNA in the spleen. These responses induced by α-GalCer R-ADCC as described above. The ability of α-GalCer-activated CD4 ϩ T cells and CD8 ϩ T cells to produce IFN-γ was were totally dependent on NKT cells, because these effects of α-GalCer were absent in NKT-deficient mice. Moreover, determined after culture with IL-2 (20 U/ml; kind gift from Shionogi Pharmaceutical Institute, Osaka, Japan) plus IL-12 α-GalCer did not exhibit any immunostimulatory effect in CD1d -/-mice. These data are summarized in Table 1 . Thus, (20 U/ml; kindly donated by Genetics Institute, Cambridge, MA) for 2 days. IFN-γ levels in culture supernatants were α-GalCer exhibits a variety of immunopotentiating effects in a CD1d-dependent fashion. measured by ELISA. (data not shown). Surprisingly, we also found that α-GalCer stimulated the expression of CD69 antigen on CD4 ϩ T cells, CD8 ϩ T cells, B cells and macrophages within 4 h after α-GalCer treatment (Fig. 1B-J) . To evaluate whether CD69 α-GalCer activates immunoregulatory cells involved in both up-regulation on macrophages, T and B cells was directly innate and acquired immunity induced by α-GalCer or indirectly induced via the activation of NKT cells, we examined the effect of α-GalCer administraTo assess whether α-GalCer, in addition to its effects on NKT cells, also influences the function of other immunoregulation on CD69 antigen expression in CD1d -/-and NKT-deficient mice. As illustrated in Fig. 2 , neither CD1d -/-nor NKT-deficient tory cells, we examined the effect of this agent on the acquisition of the early activation marker CD69 on NKT, mice revealed significant up-regulation of CD69 antigen expression on spleen cells. These data demonstrated that macrophages, T and B cells. As shown in Fig. 1(A and  F) , CD69 antigen expression on NK1.1 ϩ cells was greatly the acquisition of CD69 antigen on T cells, B cells and macrophages was not induced by direct stimulation with enhanced 4 h after the injection of α-GalCer in vivo. Further analysis by three-color flow cytometry demonstrated that α-GalCer but was secondary to the activation of NKT cells.
A critical role of CD40-CD40L interactions in bridging innate and acquired immunity by NKT cells
As reported previously (19), CD40-CD40L interaction between NKT cells and α-GalCer-bound CD1d ϩ DC is critically important for the induction of IFN-γ production by NKT cells. To examine the role of CD40-CD40L interaction for the activation of CTL by α-GalCer, the effect of anti-CD40L injection was investigated. In vivo administration of anti-CD40L mAb caused almost complete inhibition of IFN-γ production by NKT cells (Fig. 5A ). In addition, anti-CD40L mAb strongly inhibited the final development of CD69 ϩ CD8 ϩ CTL from CD69 ϩ CD8 ϩ T cells induced by α-GalCer administration (Fig. 5B) . These results strongly suggest an important role for CD40-CD40L interaction with sequential activation of NKT cells and CD69 ϩ CD8 ϩ CTL by α-GalCer in vivo. suggested that NKT cells regulate antigen-specific IgE production, suggesting that NKT cells may play a pivotal role in communication between innate immunity and acquired Bridging of innate and acquired immunity by α-GalCer-activimmunity (16,25). However, the finding that CD1d-and β 2 -ated NKT cells microglobulin-deficient mice, that lack NKT cells, exhibited normal levels of T h 2 responses and IgE production made To investigate whether the acquisition of CD69 on T cells has this issue controversial (26, 27) . Thus, direct evidence that functional implications, total CD8 ϩ , total CD4 ϩ , CD69 -CD8 ϩ , NKT cells play an essential role in the bridging between CD69 -CD4 ϩ , CD69 ϩ CD8 ϩ or CD69 ϩ CD4 ϩ T cells were isolinnate and acquired immunity has not yet been available. ated from the spleen of control or α-GalCer-injected mice by
To evaluate this issue, we tested whether the NKT cell cell sorting, and their IFN-γ-producing activity and cytotoxicity ligand α-GalCer could stimulate T cells and B cells involved was compared. The IFN-γ-producing ability of the cells was in acquired immunity. Recently, Koezuka et al. (17,18) determined after culture with IL-2 and IL-12 for 2 days. The described a novel NKT cell-specific ligand, α-GalCer, which non-specifically activated CTL activity was determined by is a natural product isolated from marine sponges. α-GalCer measuring R-ADCC CTL activity against P815 mastocytoma can stimulate NK activity and cytokine production by NKT cells cells in the presence of anti-CD3 mAb. As shown in Fig. 3 , and exhibits potent antitumor activity in vivo (15). The finding α-GalCer administration caused a significant enhancement that wild-type mice but not CD1d -/-or NKT-deficient mice of IFN-γ production by both CD8 ϩ and CD4 ϩ T cells, and respond to α-GalCer suggests that both NKT cells and CD1 ϩ these cells were markedly enriched in CD69 ϩ CD4 ϩ T cells DC are important for the activation of immune responses to or CD69 ϩ CD8 ϩ T cells. Moreover, R-ADCC CTL activity of α-GalCer (17). Indeed, we and others clearly demonstrated CD8 ϩ T cells but not CD4 ϩ T cells was significantly enhanced that α-GalCer selectively stimulated CD4 ϩ NK1.1 ϩ NKT cells by α-GalCer administration. This enhancement of CTL activity to induce NK and cytokine production in the presence of became more evident when CD69 ϩ CD8 ϩ T cells were CD1d ϩ DC in vitro (19, 24) . We also demonstrated that the enriched by cell sorting. No significant R-ADCC was detected immunostimulating effect of α-GalCer was initiated by CD40-in CD69 -CD8 ϩ T cells and CD4 ϩ T cell subpopulations.
CD40L-mediated NKT-DC interactions (19). Consistent with Moreover, α-GalCer administration into mice that were hyperthese findings, α-GalCer showed a variety of immunoregulaimmunized with syngeneic MBL-2 T lymphoma cells resulted tory functions in vivo and these effects were absent in both in the development of CD69 ϩ CD8 ϩ T cells which gave rise CD1d -/-and NKT-deficient mice (Table 1) . Using the newly to IFN-γ-producing and MBL-2-specific CTL after culture with defined NKT-specific glycolipid antigen, α-GalCer, it became IL-2 and IL-12 for 2 days (Fig. 4) . Such CTL were not induced possible to investigate the role of NKT cells in triggering in total CD8 ϩ T cells or CD69 -CD8 ϩ T cell populations. acquired immunity. Our results showed that NKT cells influTherefore, up-regulation of CD69 antigen is closely linked ence immune responses mediated by conventional CD4 ϩ with the functional maturation of CD8 ϩ CTL and CD4 ϩ T h cells.
T
cells, CD8 ϩ T cells and B cells. From these results we concluded that NKT cells activated with
To test the activation status of lymphoid cells early after α-GalCer presented by CD1d-expressing DC play a critical role in initiating T cell-and B cell-mediated acquired immunity.
α-GalCer injection, we measured the expression of early- Fig. 4 . In vivo administration of α-GalCer induces CD8 ϩ CD69 ϩ T cells, which differentiate into tumor-specific CD8 ϩ CTL. Mice hyperimmunized with MBL-2 T lymphoma cells were prepared as described in Methods. α-GalCer was i.p. injected into the MBL-2-immunized mice twice and 6 h later their spleen cells were prepared to isolate CD8 ϩ T cell subsets (CD8 ϩ , CD8 ϩ CD69 -or CD8 ϩ CD69 ϩ T cells) (hatched bars). As a control, CD8 ϩ T cells were isolated from vehicle-treated immunized mice. The isolated cells (2 ϫ10 5 /well) were cultured with IL-2 (20 U/ml) plus IL-12 (20 U/ml) for 2 days and their cytokine producing ability (A) or their ability to differentiate into CTL (B) was determined. The specific cytotoxicity was determined using 51 Cr-labeled MBL-2 lymphoma cells (hatched bars). As a control target, B16 syngeneic melanoma cells were used (closed bars). IFN-γ activity in culture supernatants was measured by ELISA. The bars represent mean Ϯ SE of triplicate samples.
are stimulated by NKT cell-specific ligand. First, α-GalCer by itself may stimulate the expression of CD69 antigen on T cells and B cells in addition to NKT cells. Second, α-GalCeractivated NKT cells in the presence of CD1 ϩ DC may act as immunoregulating cells to bridge innate and acquired immunity.
To address this issue, we investigated whether α-GalCerinduced up-regulation of CD69 antigen expression on T and B cells occurs in the absence of CD1 ϩ DC or NKT cells using CD1d -/-or NKT-deficient mice. As shown in Fig. 2 , neither CD1d -/-nor NKT-deficient mice revealed induction of CD69 antigen expression on T and B cells. Therefore, α-GalCer by showed only low levels of cytokine production and R-ADCC CTL activity after culture with IL-2 and IL-12. Moreover, α-GalCer administration into mice hyperimmunized with activation antigen CD69 on various lymphoid cells by flow syngeneic MBL-2 tumor cells induced the generation of cytometry. CD69 antigen is a type II integral membrane antigen-specific CTL from CD69 ϩ CD8 ϩ T cells, but not from protein with a C-type lectin-binding domain and a member of CD69 -CD8 ϩ T cells in the presence of IL-2 plus IL-12 ( to GPI-anchored antigens (25) . Thus, our data presented here that immunodeviation through the control of NKT cell function 17 Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., may be a useful strategy for the modulation of acquired Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M. 1997. CD1d-restricted and TCR-mediated activation immunity involved in autoimmune diseases and cancer.
of V α 14 NKT cells by glycosylceramides. Science 278:1626. 18 Kobayashi, E., Motoki, K., Uchida, T., Fukushima, H. and Koezuka, Y. 1995. KRN7000, a novel immunomodulator, and its antitumor
